Monthly Archives: November 2013

Florida and its Advanced Development and Manufacturing (NANO-ADM) Center

A new ‘nano’ manufacturing facility to be located in Florida state is featured in a November 25, 2013 news item on Azonano,

Nanotherapeutics, Inc. announced today that on November 20, 2013, the Company held a Type C meeting with the U.S. Food and Drug Administration (“FDA”), providing an opportunity for the FDA to review and provide feedback on Nanotherapeutics’ plans for its Advanced Development and Manufacturing (NANO-ADM) Center facility to be located in Copeland Park, Alachua, FL.

The review and subsequent discussions with the FDA focused on its cGMP [Current Good Manufacturing Practice] manufacturing space, which will provide Nanotherapeutics with capabilities to develop and produce bulk vaccines and biologics for the Department of Defense (DOD), other government agencies and industry. The Company expressed its appreciation to the FDA for granting the meeting, which represents the achievement of a major milestone in the ongoing design of a successful NANO-ADM Center.

You can find out more about Nanotherapeutics, Inc. here and for anyone curious about cGMPs, there’s this page on the FDA website,

Current Good Manufacturing Practices (cGMPs) for human pharmaceuticals affect every American.  Consumers expect that each batch of medicines they take will meet quality standards so that they will be safe and effective.  Most people, however, are not aware of cGMPs, or how FDA assures that drug manufacturing processes meet these basic objectives.  Recently, FDA has announced a number of regulatory actions taken against drug manufacturers based on the lack of cGMPs.  This paper discusses some facts that may be helpful in understanding how cGMPs establish the foundation for drug product quality.

What are cGMPs?

cGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA).  cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities….

Prior to this latest announcement about the NANO-ADM, there was some information offered in the company’s Oct. 23, 2013 news release about the groundbreaking event,

Nanotherapeutics, Inc. today announced that a groundbreaking ceremony for its Advanced Development and Manufacturing Center (NANO-ADM) in Copeland Park, Alachua, FL, will be held this morning [Oct. 23, 2013] at 9:00 am ET. …

The ceremony celebrates the groundbreaking of the 30-acre NANO-ADM center being constructed through privately secured financing to fulfill the contract awarded to Nanotherapeutics by the US Department of Defence (DOD) earlier this year. … The goal of the contract is to enable faster and more effective development of medical countermeasures designed to treat and protect military populations against chemical, biological, radiological and nuclear attacks and outbreaks of naturally occurring, emerging and genetically engineered infectious diseases.

Nanotherapeutics and its network of 16 world-class teaming partners and collaborators for this project are currently able to furnish core services in response to the DOD’s requirements, should the need arise. … single-use equipment of one-of-a-kind, 165,000 square foot facility. The NANO-ADM Center will integrate new biomanufacturing technologies with existing capabilities enabling the development of both small molecule and biologic products. …

The Nov. 21, 2013 news release, which originated the news item on Azonano, provided this additional detail,

Construction of the NANO-ADM Center is scheduled for completion in early 2015, with commissioning, qualification and full occupancy expected by mid-March 2015.

It seems to me that while New York State has garnered a lot of attention for its nanotechnology model, as evidenced by a book on the topic: New York’s Nanotechnology Model: Building the Innovation Economy: Summary of a Symposium (2013), and much more, Florida has been quietly establishing itself as another center for nanotechnology and innovation.

Stretchable carbon nanotubes as supercapacitors

This Nov. 25, 2013 news item on phys.org was a bit of a walk down memory lane for me,

A mobile telephone display for your jacket sleeve, ECG probes for your workout clothes—wearable electronics are in demand. In order for textiles with built-in electronics to function over longer periods of time, all of the components need to be flexible and stretchable. In the journal Angewandte Chemie, Chinese researchers have now introduced a new type of supercapacitor that fulfills this requirement. Its components are fiber-shaped and based on carbon nanotubes.

The reference to a mobile telephone display on a jacket sleeve brought back memories of Nokia’s proposed Morph device,, from my Aug. 3, 2011 posting,

For anyone who’s not familiar with the Morph, it’s an idea that Nokia and the University of Cambridge’s Nanoscience Centre have been working on for the last few years. Originally announced as a type of flexible phone that you could wrap around your wrist, the Morph is now called a concept.  …

At the time I was writing about exploring the use of graphene to enable the morph (flexible phone). This latest work from China is focused on carbon nanotubes,. The Angewandte Chemie Nov. 25, 2013 press release, which originated the news item on phys.org,  provides more details,

For electronic devices to be incorporated into textiles or plastic films, their components must be stretchable. This is true for LEDS, solar cells, transistors, circuits, and batteries—as well as for the supercapacitors often used for static random access memory (SRAM). SRAM is often used as a cache in processors or for local storage on chips, as well as in devices that must maintain their data over several years with no source of power.

Previous stretchable electronic components have generally been produced in a conventional planar format, which has been an obstacle to their further development for use in small, lightweight, wearable electronics. Initial attempts to produce supercapacitors in the form of wires or fibers produced flexible—but not stretchable—components. However, stretchability is a required feature for a number of applications. For example, electronic textiles would easily tear if they were not stretchable.

A team led by Huisheng Peng at Fudan University has now developed a new family of highly stretchable, fiber-shaped, high-performance supercapacitors. The devices are made by a winding process with an elastic fiber at the core. The fiber is coated with an electrolyte gel and a thin layer of carbon nanotubes is wound around it like a sheet of paper. This is followed by a second layer of electrolyte gel, another layer of carbon nanotube wrap, and a final layer of electrolyte gel.

The delicate “sheets” of carbon nanotubes are produced by chemical vapor deposition and a spinning process. In the sheets this method produces, the tiny tubes are aligned in parallel. These types of layers display a remarkable combination of properties: They are highly flexible, tear-resistant, conductive, and thermally and mechanically stable. In the wound fibers, the two layers of carbon nanotubes act as electrodes. The electrolyte gel separates the electrodes from each other while stabilizing the nanotubes during stretching so that their alignment is maintained. This results in supercapacitor fibers with a high capacity that is maintained after many stretching cycles.

For the curious, here’s a link to and a citation for the paper,

A Highly Stretchable, Fiber-Shaped Supercapacitor by Zhibin Yang, Jue Deng, Xuli Chen, Jing Ren, and Prof. Huisheng Peng. Angewandte Chemie International Edition
Early View (Online Version of Record published before inclusion in an issue)Article first published online: 8 NOV 2013 DOI: 10.1002/anie.201307619

Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

This article is behind a paywall.

Future biomedical applications for CNC (cellulose nanocrystals, aka NCC [nanocrystalline cellulose]) from Polytechnic Institute of New York University (NYU-Poly)

It’s good to see a project that might result in applications for CNC (aka, NCC). I commented briefly about the CNC situation earlier today in my Nov. 25, 2013 posting about Lomiko Metals (based in Surrey, BC, Canada) and its focus on developing markets for its product (graphite flakes/graphene). By contrast, Canada’s CelluForce plant (in Québec) has stopped production to avoid adding to its stockpile (as per my Oct. 3, 2013 posting), Alberta has launched a pilot CNC plant (my Nov. 19, 2013 posting), Blue Goose Biorefineries in Saskatchewan was ramping up production according to my May 7, 2013 posting and someone, in a blog posting comment, claimed that Pure Liganin in BC produces CNC (which I cannot confirm since the company mentions neither CNC nor NCC).,

Back to happier matters, a research team from Polytechnic Institute of New York University (NYU-Poly) has discovered information that could be helpful for scientists working with protein polymers (from the Nov. 22, 2013 news item on Azonano,,

A team of researchers has uncovered critical information that could help scientists understand how protein polymers interact with other self-assembling biopolymers. The research helps explain naturally occurring nano-material within cells and could one day lead to engineered bio-composites for drug delivery, artificial tissue, bio-sensing, or cancer diagnosis.

The Nov. 21, 2013 NYU-Poly press release, which originated the news item, goes on to explain the CNC connection to this work,

Bionanocomposites provide a singular area of research that incorporates biology, chemistry, materials science, engineering, and nanotechnology. Medical researchers believe they hold particular promise because—unlike the materials that build today’s medical implants, for example—they are biodegradable and biocompatible, not subject to rejection by the body’s immune defenses. As biocomposites rarely exist isolated from other substances in nature, scientists do not yet understand how they interact with other materials such as lipids, nucleic acids, or other organic materials and on a molecular level. This study, which explored the ways in which protein polymers interact with another biopolymer, cellulose, provides the key to better understanding how biocomposite materials would interact with the human body for medical applications.

The materials analyzed were composed of bioengineered protein polymers and cellulose nanocrystals and hold promise for medical applications including non-toxic, targeted drug delivery systems. [emphasis mine] Such bionanocomposites could also be used as scaffolding for tissue growth, synthetic biomaterials, or an environmentally friendly replacement for petroleum-derived polymers currently in use.

I wonder if the researchers obtained their CNC from the production plant in Wisconsin (US), assuming it has opened since my July 27, 2012 posting featuring an announcement of future plans. Getting back to this latest work, here’s a link to and a citation for the paper,

Bionanocomposites: Differential Effects of Cellulose Nanocrystals on Protein Diblock Copolymers by Jennifer S. Haghpanah, Raymond Tu, Sandra Da Silva, Deng Yan, Silvana Mueller, Christoph Weder, E. Johan Foster, Iulia Sacui, Jeffery W. Gilman, and Jin Kim Montclare. Biomacromolecules, Article ASAP DOI: 10.1021/bm401304w Publication Date (Web): October 18, 2013
Copyright © 2013 American Chemical Society

This paper is behind a paywall.

Offhand I can think of only one Canadian laboratory (although I’m certain there are others), which is working on applications for CNC and that’s Mark MacLaclan’s lab at the University of British Columbia (UBC). For example, there is this ‘in press’ paper,

Shopsowitz, K.E.; Kelly, J.A.; Hamad, W.Y.; MacLachlan, M.J. “Biopolymer Templated Glass with a Twist: Controlling the Chirality, Porosity, and Photonic Properties of Silica with Cellulose Nanocrystals” Adv. Funct. Mater. 2013, in press. DOI: 10.1002/adfm.201301737

You can find more about MacLachlan’s work here.

New book ‘Wonder of Nanotechnology’ explores optical and electronic systems

Nature is nano.

Nature starts with the atom, the building block of all matter, and works hand-in-hand with her partner the photon, the piece of light that communicates energy from one atom to another.When nature binds atoms together or creates physical structures in the micro- and nano-range, the combinations interact differently with light, providing nature with a rich palette of colors to decorate the world around us,while also giving rise to the functional complexity of nature.The wings of a butterfly, the feather of a peacock, the sheen of a pearl—all of these are examples of nature’s photonic crystals: nanostructured arrangements of atoms that capture and recast the colors of the rainbow with iridescent beauty. These diverse combinations of microstructures and atoms in molecules, crystals, proteins, and cells on the nanoscale eventually give rise to ourselves, sentient beings, who, in turn, strive to explain the natural world that we see around us.. (from the Preface for the Wonder of Nanotechnology)

The Nov. 21, 2013 SPIE, the international society for optics and photonics news release touting the book is a little more restrained than the dramatic ‘Nature is nano’,,

BELLINGHAM, Washington, USA – Nanotechnology research has progressed into quantum-level systems where electrons, photonics, and even thermal properties can be engineered, enabling new structures and materials with which to create ever-shrinking, ever-faster electronics. The Wonder of Nanotechnology: Quantum Optoelectronic Devices and Applications, edited by Manijeh Razeghi and Nobel Laureates Leo Esaki and Klaus von Klitzing, focuses on the application of nanotechnology to modern semiconductor optoelectronic devices The book is published by SPIE, the international society of optics and photonics.

The volume is a compilation of research papers from the International Conference on Infrared Optoelectronics at Northwestern University’s Center for Quantum Devices in September 2012, developed into chapters representing state-of-the-art research in infrared materials and devices.

“Advances in material science at the nanometer scale are opening new doors in the area of optics and electronics. The ability to manipulate atoms and photons, and fabricate new material structures offers opportunities to realize new emitters, detectors, optics, ever-shrinking electronics, and integration of optics and electronics,” writes Nibir Dhar, program manager with Defense Advanced Research Project Agency (DARPA), in an essay in the book. “Imaging technology has the opportunity to leverage these developments to produce new products for military, industrial, medical, security, and other consumer applications.”

The editors of Wonder of Nanotechnology are:

  • Manijeh Razeghi, director of the Center for Quantum Devices at Northwestern University and one of the leading scientists in the field of semiconductor science and technology. Razeghi pioneered nanometer-scale architectures in semiconductor technology, and her research in quantum materials has culminated in various technologies such as type-II strained-layer superlattice infrared detectors, lasers, and terahertz technology. Her current interest is in nanoscale optoelectronic quantum devices.
  • Leo Esaki, who shared the 1973 Nobel Prize in Physics for his discovery of the phenomenon of electron tunneling while working at Tokyo Tsushin Kogyo (now known as Sony). He is known for his invention of the Esaki diode, which exploited that phenomenon. He also pioneered the development of the semiconductor superlattice while at IBM, and is president of the Yokohama College of Pharmacy in Japan.
  • Klaus von Klitzing, director of the Max Planck Institute for Solid State Research in Germany. Von Klitzing was awarded the 1985 Nobel Prize in Physics for his discovery of the integer quantum Hall effect. His current research focuses on the properties of low-dimensional electronic systems, typically in low temperatures and in high magnetic fields.

“The chapters in this book bear witness to how far we have come since the invention of manmade semiconductor superlattices in 1969,” Esaki writes in the book’s foreword. “I look back with wonder at all of the exciting developments of the last 44 years and can only imagine where the future will take this technology and what exciting discoveries await.”

The book’s editors also address the inspiration of nature in studying nanoscale structures, and how the human ability to control material composition on the nanometer scale is what allows us to achieve technological goals transcending the properties of naturally occurring materials.

“The wings of a butterfly, the feather of a peacock, the sheen of a pearl — all of these are examples of nature’s photonic crystals: nanostructured arrangements of atoms that capture and recast the colors of the rainbow with iridescent beauty,” von Klitzing writes in the book’s preface. “As our tools to manipulate matter reach ever smaller length scales, we, too, are able to join in the game of discovery in the nano-world — a game that nature has long since mastered.”

Notable chapters include:

  • “Advances in High-Power Quantum Cascade Lasers and Applications” by Arkadiy Lyakh, Richard Maulini, Alexei Tsekoun, and Boris Tadjikov (Pranalytica, Inc.), and CO2-laser inventor Kumar Patel (Pranalytica, Inc., and University of California Los Angeles)
  • “Type-II Superlattices: Status and Trends” by Elena Plis and Sanjay Krishna (Center for High-Technology Materials, University of New Mexico)
  • “Quantum Dots for Infrared Focal Plane Arrays Grown by MOCVD” by Manijeh Razeghi and Stanley Tsao (Center for Quantum Devices, Northwestern University)
  • “Quantum-Dot Biosensors using Fluorescence Resonance Energy Transfer (FRET)” by James Garland and Dinakar Ramadurai (Episensors, Inc., and Sivananthan Laboratories, Inc.) and Siva Sivananthan (Sivananthan Laboratories, Inc., and University of Illinois)
  • “Nanostructured Electrode Interfaces for Energy Applications” by Palash Gangopadhyay, Kaushik Balakrishnan, and Nasser Peyghambarian (College of Optical Sciences, University of Arizona)

You can go here to purchase the book.

Lomiko Metals and Graphene Laboratories announce 3D printing spinoff company

A Nov. 25, 2013 news item on Azonano announces a new 3D printing company, Graphene 3D Labs,

LOMIKO METALS INC. (the “Company”) announced today the formation of Graphene 3D Labs Inc. to focus on the development of high-performance graphene-enhanced materials for 3D Printing. Dr. Daniel Stolyarov of Graphene Laboratories Inc. (“Graphene Labs”) was appointed CEO and Dr. Michael Gouzman, a leading expert in 3D Printing, was appointed VP of Engineering and Technology.

On February 12, 2013 the Company had entered into a Strategic Alliance Agreement (“SAA”) with Graphene Labs. The creation of Graphene 3D Labs, a spin-out of Graphene Labs, is a result of R&D efforts during the duration of the SAA.

It’s been a busy year for Lomiko Metals (based in Surrey, BC, Canada) as per my April 17, 2013 posting about its graphite flake testing and its graphite mine (Quatre Milles) in Québec and my May 30, 2013 posting about its agreement/strategic alliance with the Research Foundation of Stony Brook University (RF) based in New York State. This latest effort according to the Nov. 22, 2013 Lomiko Metals news release, which originated the news item, describes the reasons for creating a spinout company to pursue applications,

3D Printing is a new and promising manufacturing technology that has garnered much interest, growing from uses in prototyping to everyday products. Today, it is a billion dollar industry growing at a brisk pace. New developments in 3D printing will allow products with different components such as printed electronic circuits, sensors or batteries to be manufactured.

High quality graphite is a base material for producing graphene. Lomiko will provide graphite to Graphene 3D Labs as the exclusive supplier to Graphene 3D Labs and invest $ 50,000 in the start-up for 250,000 preferred shares which are entitled to dividends. Lomiko will require a minimum of $ 300,000 financing by May 1, 2014 to participate in the venture and further financings to participate in a series of graphene-related ventures in addition to work on a graphite resource at the Quatre Milles Project. The transaction is arm’s length and subject to the approval of the TSX. [Toronto Stock Exchange]

“Our involvement in Graphene 3D Labs is a concrete first step into the world of Graphene, 3D Printing and Printed Electronics. This is a rapidly developing new market for high quality naturalgraphite.” stated A. Paul Gill, CEO from the Graphene Live! Conference in Santa Clara, California held November 19-22, 2013.

Dr. Elena Polyakova, CEO of Graphene Labs, was a speaker on Graphene Live! and stated, “We anticipate graphene-enabled materials to revolutionize 3D printing. We anticipate strong demand in airspace, automotive, semi-conductor and advanced manufacturing industries.”

Currently Lomiko and Graphene Labs are working toward the integration of graphene-based products into end-user goods as set out in the Strategic Alliance. [emphasis mine] Lomiko’s high quality graphite and the extensive customer database cultivated by the experts at Graphene Labs will prove indispensable to reaching production and commercialization goals.

This business of developing a market for your raw materials is an approach the folks at CelluForce in Quebec and the new CNC (cellulow nanocrytals, aka, nanocystalline cellulose [NCC]) plant in Alberta might consider taking, if they haven’t already. (Note: My Nov. 19, 2013 posting both announces the new CNC in Alberta and makes mention of the CNC stockpile in  Québec.)

You can find out more about Graphene Laboratories here and about Graphene 3D Laboratories here. For anyone interested in the Graphene Live! conference, (Nov. 20-21, 2013), there will be presentations and audio available soon (as of Nov. 25, 2013) according to the website.

Graphene and your sex life

This is a first, as far as I know, for graphene, which is usually discussed in the context of electronics. A research team at the University of Manchester (where it was first isolated by Andre Gerim and Kostya Novoselov in 2004) has won a research grant to develop condoms made of graphere, from the Nov. 22, 2013 news item on Azonano,

Wonder material graphene faces its stiffest challenge yet – providing thinner, stronger, safer and more desirable condoms.

Dr Aravind Vijayaraghavan and his team from The University of Manchester have received a Grand Challenges Explorations grant of $100,000 (£62,123) from the Bill and Melinda Gates Foundation to develop new composite nano-materials for next-generation condoms, containing graphene.

Dr Vijayaraghavan took on a challenge that had been presented to inventors around the world– to develop new technology that would make the condom more desirable for use, which could lead to an increase in condom use.

Here’s how the challenge was presented in March 2013 (from the Develop the Next Generation of Condom challenge webpage on the Grand Challenges (the Bill & Melinda Gates Foundation) website,

Male condoms are cheap, easy to manufacture, easy to distribute, and available globally, including in resource poor settings, through numerous well developed distribution channels.  The current rate of global production is 15 billion units/year with an estimated 750 million users and a steadily growing market. …

The one major drawback to more universal use of male condoms is the lack of perceived incentive for consistent use. The primary drawback from the male perspective is that condoms decrease pleasure as compared to no condom, creating a trade-off that many men find unacceptable, particularly given that the decisions about use must be made just prior to intercourse. …

Likewise, female condoms can be an effective method for prevention of unplanned pregnancy or HIV infection, but suffer from some of the same liabilities as male condoms, require proper insertion training and are substantially more expensive than their male counterparts. …

The Challenge: 

Condoms have been in use for about 400 years yet they have undergone very little technological improvement in the past 50 years. The primary improvement has been the use of latex as the primary material and quality control measures which allow for quality testing of each individual condom. Material science and our understanding of neurobiology has undergone revolutionary transformation in the last decade yet that knowledge has not been applied to improve the product attributes of one of the most ubiquitous and potentially underutilized products on earth. New concept designs with new materials can be prototyped and tested quickly.  Large-scale human clinical trials are not required. Manufacturing capacity, marketing, and distribution channels are already in place.

We are looking for a Next Generation Condom that significantly preserves or enhances pleasure, in order to improve uptake and regular use. Additional concepts that might increase uptake include attributes that increase ease-of-use for male and female condoms, for example better packaging or designs that are easier to properly apply. In addition, attributes that address and overcome cultural barriers are also desired.  Proposals must (i) have a testable hypothesis, (ii) include an associated plan for how the idea would be tested or validated, and (iii) yield interpretable and unambiguous data in Phase I, in order to be considered for Phase II funding.

A few examples of work that would be considered for funding:

  • Application of safe new materials that may preserve or enhance sensation;
  • Development and testing of new condom shapes/designs that may provide an improved user experience;
  • Application of knowledge from other fields (e.g. neurobiology, vascular biology) to new strategies for improving condom desirability.

The project’s team leader, Dr Vijayaraghavan had a few things to say about the possibilities for this composite material (graphene and latex) they are hoping to develop (from the Nov. 21, 2013 University of Manchester news release, which originated the news item on Azonano),

Dr Vijayaraghavan said: “This composite material will be tailored to enhance the natural sensation during intercourse while using a condom, which should encourage and promote condom use.

“This will be achieved by combining the strength of graphene with the elasticity of latex, to produce a new material which can be thinner, stronger, more stretchy, safer and, perhaps most importantly, more pleasurable.”

He also comments on the impact of this project: “Since its isolation in 2004, people have wondered when graphene will be used in our daily life. Currently, people imagine using graphene in mobile-phone screens, food packaging, chemical sensors, etc.

“If this project is successful, we might have a use for graphene which will literally touch our every-day life in the most intimate way.”

I wonder who will be testing these condoms when the time comes.

For anyone who wants to know more about the graphene story, there are these postings (excerpted from my Jan. 3, 2012 posting about their then newly acquired knighthoods): regarding Geim and Novoselov’s work and their Nobel prizes, “my Oct. 7, 2010 posting, which also features a video of a levitating frog (one of Geim’s favourite science stunts) and my Nov. 26, 2010 posting features a video demonstrating how you can make your own graphene sheets.”

One final note, I posted about the Canadian Grand Challenges funding (not be contused with the US-based Bill and Melinda Gates Foundation programme) in this Nov. 21, 2013 posting.

Australians inspired by Lycurgus Cup

The Lycurgus Cup is one of the great artistic achievements in history and there’s a nanotechnology twist to this art work created in the 4th century CE (or AD). From the Nov. 21, 2013 news item on Nanowerk,

A 1700-year-old Roman glass cup is inspiring University of Adelaide [Australia] researchers in their search for new ways to exploit nanoparticles and their interactions with light.

Researchers in the University’s Institute for Photonics and Advanced Sensing (IPAS) are investigating how to best embed nanoparticles in glass – instilling the glass with the properties of the nanoparticles it contains.

Before going further with this latest work at the University of Adelaide, here’s an excerpt from my Sept. 21, 2010 posting where I burbled on about the best of piece of writing I’ve seen about the Lycurgus Cup (held in the British Museum),

The *History of the Ancient World website (as Nov. 21, 2013 the link has been changed to the Université de Strasbourg,, Matière Condensée et Nanophysique website) recently featured a 2007 article about the Lycurgus Cup by Ian Freestone, Nigel Meeks, Margaret Sax and Catherine Higgitt for the Gold Bulletin, Vol. 40:4 (2007),

The Lycurgus Cup represents one of the outstanding achievements of the ancient glass industry. This late Roman cut glass vessel is extraordinary in several respects, firstly in the method of fabrication and the exceptional workmanship involved and secondly in terms of the unusual optical effects displayed by the glass.

The Lycurgus Cup is one of a class of Roman vessels known as cage cups or diatreta, where the decoration is in openwork which stands proud from the body of the vessel, to which it is linked by shanks or bridges Typically these openwork “cages” comprise a lattice of linked circles, but a small number have figurative designs, although none of these is as elaborate or as well preserved as the Lycurgus Cup. Cage cups are generally dated to the fourth century A.D. and have been found across the Roman Empire, but the number recovered is small, and probably only in the region of 50-100 examples are known. They are among the most technically sophisticated glass objects produced before the modern era.

Here’s what it looks like,

The Lycurgus Cup 1958,1202.1 in reflected light. Scene showing Lycurgus being enmeshed by Ambrosia, now transformed into a vine-shoot. Department of Prehistory and Europe, The British Museum. Height: 16.5 cm (with modern metal mounts), diameter: 13.2 cm. © The Trustees of the British Museum

The Lycurgus Cup 1958,1202.1 in reflected light. Scene showing Lycurgus being enmeshed by Ambrosia, now transformed into a vine-shoot. Department of Prehistory and Europe, The British Museum. Height: 16.5 cm (with modern metal mounts), diameter: 13.2 cm. © The Trustees of the British Museum

And this, too, is the one and only Lycurgus Cup,

The Lycurgus Cup 1958,1202.1 in transmitted light. Scene showing Lycurgus being enmeshed by Ambrosia, now transformed into a vine-shoot. Department of Prehistory and Europe, The British Museum. Height: 16.5 cm (with modern metal mounts), diameter: 13.2 cm. © The Trustees of the British Museum

The Lycurgus Cup 1958,1202.1 in transmitted light. Scene showing Lycurgus being enmeshed by Ambrosia, now transformed into a vine-shoot. Department of Prehistory and Europe, The British Museum. Height: 16.5 cm (with modern metal mounts), diameter: 13.2 cm. © The Trustees of the British Museum

The Nov. 21, 2013 University of Adelaide, news release, which originated the news item, explains why the Lycurgus Cup is of such interest, and why the same cup can be green or red

The Lycurgus Cup, a 4th century cup held by the British Museum in London, is made of glass which changes colour from red to green depending on whether light is shining through the Cup or reflected off it. It gets this property from gold and silver nanoparticles embedded in the glass.

“The Lycurgus Cup is a beautiful artefact which, by accident, makes use of the exciting properties of nanoparticles for decorative effect,” says Associate Professor Ebendorff-Heidepriem. “We want to use the same principles to be able to use nanoparticles for all sorts of exciting advanced technologies.”

Nanoparticles need to be held in some kind of solution. “Glass is a frozen liquid,” says Associate Professor Ebendorff-Heidepriem. “By embedding the nanoparticles in the glass, they are fixed in a matrix which we can exploit.”

Associate Professor Ebendorff-Heidepriem is leading a three-year Australian Research Council Discovery Project to investigate how best to embed nanoparticles; looking at the solubility of different types of nanoparticles in glass and how this changes with temperature and glass type, and how the nanoparticles are controlled and modified.

Practical applications, according to the news release, include,

“Nanoparticles and nanocrystals are the focus of research around the world because of their unique properties that have the potential to bring great advances in a wide range of medical, optical and electronic fields,” says Associate Professor Heike Ebendorff-Heidepriem, Senior Research Fellow in the University’s School of Chemistry and Physics. “A process for successfully incorporating nanoparticles into glass, will open the way for applications like ultra low-energy light sources, more efficient solar cells or advanced sensors that can see inside the living human brain.”

“We will be able to more readily harness these nanoscale properties in practical devices. This gives us a tangible material with nanoparticle properties that we can shape into useful forms for real-world applications. And the unique properties are actually enhanced by embedding in glass.”

Grenelabs and its indiegogo crowdfunding campaign for a handheld diagnostic device

Grenelabs has just started anindiegogo campaign to raise money for its lab-on-a-chip handheld diagnostic equipment or as they call it, ‘Lab-on-a-chip: Diagnostics in the Palm of Your Hand‘. I received a Nov. 19, 2013 news release (as happens more frequently these days) about the effort,

Thomas Warinner, head of Grenelabs, seeks crowdfunding to raise $75,000 by December 20, 2013 (11:59 pm PT), www.indiegogo.com/projects/lab-on-a-chip-diagnostics-in-the-palm-of-your-hand, to support the completion of the technologically new, lab-on-a chip diagnostic tool. This device, small enough to fit in the palm of a hand, is designed using reliable scientific knowledge coupled with breakthrough technology. It enables users to diagnose diseases within minutes without electricity and costly upkeep, making it ideal for use in developing countries around the world and by independent research labs whose funds are oftentimes limited.

“Imagine a world in which developing countries can have access to technologies in order to diagnose and prevent the spread of diseases,” said Thomas Warinner, creator of the lab-on-a-chip device. “The importance of these chips is not to just open up research, but to identify illnesses in people who could otherwise not be diagnosed.” Many of these are illnesses that could be contained and treated, if caught in time, rather than allowing them to run rampant, sickening or killing people and/or animals.

So how does it work? Basically, the lab-on-a chip manipulates liquids in capillary tubes within the chip based on the science of microfluidics. For example, a drop of blood is sent past biomarkers that change when positive. Although disposable, the lab-on-a-chip is designed to be accurate over multiple uses. Grenelabs developed the ability to perform diagnostic testing in any setting, making it useful in disaster situations, remote areas, and developing countries. “This technology will change the world,” Warinner said of his innovative tool that measures half the size of a credit card. But, in order to move forward, funding is needed.

In an effort to raise funds, support levels have been created. Choose a dollar amount and receive the assigned perk. For instance, a $55 donation will give the donor a digital copy of a huge modern art mural with DNA sequencing; a $125 donation will reward the contributor with a lab-on-a-chip engraved with the contributor’s name to be given to an area in need; a $500 donation gets the supporter a special work of art with an individualized DNA sequencing as the focus; and a $1200 donation allows givers to conduct their own genetic experiments with an electrophoresis unit deliverable by January 2014.

While the initial goal is to collect $75,000 for finalization and production of the chip, more money is needed to improve the lab-on-a-chip’s reach. With $200,000, an upgraded software system will allow all users, inexperienced and experienced, to utilize the chip. With $500,000, the number of diseases and infections that can be recognized by the device would increase. And imagine having a personal diagnostic system at home; with $1,000,000, that would be a possibility.

Support the campaign through monetary donation or by simply sharing the lab-on-a-chip’s fundraising page with others through word of mouth or social media sites. With support, the lab-on-a-chip will soon be making a positive difference in the world.

About Grenelabs

Grenelabs is founded by Thomas Warinner. With a mission to provide affordable and accessible learning tools to researchers around the world, the company developed the lab-on-a-chip device to be a convenient, affordable and useful tool for people around the world.

It seems like a well-intentioned project but its a little hard to tell what makes it different from all of the other hand-held diagnostic projects. I did take a look at the Grenelabs website and was not able to get any more information about the folks behind this project or about any other projects they may have underway. It’s early days yet and I’m sure they’ll refine their pitch (perhaps a find a distinctive name for their project?) as they continue to seek funds.

Interestingly (to me) the news release for this campaign,was written and sent by L&C, a company devoted to the promotion of crowdfunding campaigns according to its About Us page,

We are obsessed with great design & quality content and that’s one of the reasons L&C became successful in the first place. Each crowdfund project we publish goes through quality control and has to be approved by L&C’s crowdfunding experts in order to get showcased. By following this strategy we’ve managed to showcase 100′s of crowdfund projects to the public.

“We showcase the coolest crowdfund projects of the web”

We’ve helped entrepreneurs and innovators turn brilliant ideas into realily and are proud of that. We are dedicated in finding the coolest crowdfund projects of the web and in making your life easier, that’s our goal, that’s our passion and 1000′s of visitors per day must mean we are doing something right.

If you want to:

  • Reach a wider audience
  • Inspire people to visit your campaign page
  • Convince people to back your crowdfund project
  • Promote your project across multiple channels
  • Use the very latest marketing methods that are proven to produce results

If any of the above sounds familiar, L&C Media Buzz is the team for you.

Who We Are

Our team at L&C draws on years of promotional and marketing experience in the online and physical communities. We make it our job to keep up to date with cutting edge techniques so that you can always be sure your project is being presented in the very best light to your target audiences.

We know how important it is to focus on presenting the right message to the right people at the right time. Our professional team of copywriters and marketing experts have all the crowdfund promotion tools you could ask for and more.

What We Do

Whether you are trying to fund an exciting new product or pay for a family member’s medical expenses, there are people out there that will be willing to help. But in order to help, those people need to know about your project.

By employing a combination of proven marketing methods executed with the flare and panache of marketing veterans, L&C Media Buzz can instantly improve your crowdfunding project’s visibility. Some of those proven techniques include:

  • Content Optimization
  • Professionally Written Press Releases with Global Distribution
  • Content Marketing
  • Multimedia Web Promotion
  • Headline Display in Time Square

With our helping hands, you can reach out to a wider audience and really showcase your campaign in all its glory.

Not for Everyone

Some people might think that having a campaign on the internet and writing an article about it will do the job. If the project is good then the people will come… won’t they?
The truth, unfortunately, is no. Just because something is there, doesn’t mean people will see it.

More than that, even if you have the most amazing cause or product to raise funds for, people still might not want to make a financial investment in you.
Why? Because investing in somebody is a risk. Especially if you don’t know that person.

In order to fulfill your campaign goals, you will need a crowdfund promotion plan that isn’t just seen by potential backers, but one that inspires investors to take a chance on you. This takes skill and expertise. The skill and expertise that that not everyone possesses. The skill and expertise that L&C possesses.

  • Professional writers will craft press releases that will be distributed worldwide to attract potential backers.
  • Copywriters will carefully design engaging blogs about your campaign that highlight exactly why people need to invest in your dream right now.
  • L&C will post blogs on our very own blog page (blog.lncdeslet.com) which, with a little help of our SEO experts, gets visitors from all over the world.
  • In short, we cover all marketing angles to help drive targeted traffic to your crowdfunding campaign.

Easy for You

Here at L&C we understand that your main priority should be focusing on bringing your project to life. That’s why we offer to take all the hard work and stress out of crowdfund promotion.

Using our professional, effective marketing services couldn’t be easier. We use packages which combine various marketing components from social media promotion to crowdfund consultation. Whichever package you choose, you will have a personal campaign manager who will oversee your crowdfund promotion plan from beginning to end to ensure excellent continuity across all marketing channels.

We at L&C don’t believe in hidden fees which is why each package is paid for up front with a one off fee. Once you have chosen the package that best suits your campaign’s needs, you can fill out the details in the forms provided to make sure your promotional material fits your unique goal, pay the fee and then sit back and let us work our marketing magic.

Our crowdfund promotion packages raise your campaign up on a pedestal for your investors to see clearly.

Based on what I see for Warriner’s campaign, I hope L&C will help the Grenelabs folks to better understand the audience for what appears to be a well intentioned project.

Science Borealis (new Cdn. science blog aggregator) and intellectual property sessions at the 5th Canadian Science Policy Conference

Science Borealis, a Canadian science blogging aggregator, being launched at the 2013 (5th annual) Canadian Science Policy Conference (CSPC) in Toronto, Ontario (from Nov. 20 – 22, 2013). Mike Spear will be giving a preview of sorts at today’s luncheon and later there will a panel session about science blogger where Sarah Boon (one of the founding members) will officially launch the aggregator. Here’s more from the Nov. 21, 2013 Science Boreaiis news release (full disclosure: I am a member of the founding team),

Science Blogging Discussion Marks the Launch of Science Borealis

Science Borealis plans to feature up to 150 Canadian science blogs

Calgary and Toronto, November 21, 2013 – After months in the making, a new chapter in Canadian science communication will launch tomorrow at the Canadian Science Policy Conference at Toronto’s Allstream Centre.

The community-driven Science Borealis blogging network will grow Canada’s science communication community, while raising awareness of – and support for – Canadian science.  After a group of bloggers started talking about the idea in late 2012, the not-for-profit organizations Canadian Science Publishing and Genome Alberta added their support, funding, and time, and Science Borealis is now ready to move out of the developer’s lab and into the forefront of Canadian science communication.

Join us tomorrow (Friday) from 1:30p – 3:00p at the Allstream Centre in Toronto for a special panel presentation on science blogging that is part of CSPC 2013. You’ll hear a discussion covering the challenges facing science blogging in Canada, find out the success stories, and meet some of Canada’s science bloggers. The Science Borealis members will be easily recognizable by their distinctive t-shirts and will be pleased to answer your questions.

The panel, ‘Science blogging in Canada: Making use of a valuable resource’ will be moderated by Genome Alberta’s Mike Spear and feature speakers:

  • Rees Kassen, Associate Professor and University Research Chair, University of Ottawa
  • Sarah Boon, Associate Professor of Environmental Science, University of Lethbridge
  • Kennedy Stewart, Member of Parliament (NDP), Burnaby-Douglas
  • David Kent, Research Associate, University of Cambridge, UK
  • Lisa Willemse, Director of Communications, Stem Cell Network

Visit Science Borealis on the web at http://scienceborealis.ca , follow @ScienceBorealis on Twitter, or check out the #cancomm hashtag on Twitter.

Here’s more about the CSPC 2013 science blogging session from the conference’s P22: Science blogging in Canada: Making use of a valuable resource webpage,,

This session will take you into the revealing, thought-provoking and sometimes wild world of science blogs. They’re out there, they’re more numerous than you might think and they have impact. They validate successful science and challenge weak conclusions. And, in today’s climate, in which research has been shadowed and/or kept silent, and traditional print media is in decline, science blogs have emerged as an increasingly important tool for providing valuable context and understanding of research via an open and public forum that encourages debate. Searching the online world for credible information is not without its challenges. The Internet is often a source of misinformation, and blogs still suffer under an outdated perception that they are simply a place for writers and ideas that can’t get published anywhere else. But this has changed dramatically in the past 10 years as powerhouse media entities such as National Geographic, Scientific American and Nature have drawn high-profile science bloggers to their staff ranks to report and comment on scientific discoveries. Many professional researchers have also turned to blogging as a way to bring avid followers, both within and outside of academia, to the front lines of research, addressing current outcomes, methods and challenges within their scientific communities. There are numerous talented science bloggers in Canada, representing both the science reporting and documentary approaches. The proposed panel will address how science blogs can be useful for policy making, and present some upcoming initiatives designed to make blogs more accessible to government, the broader scientific community, industry and the public. The session will look at traditional methods of communicating science to policymakers and identify the role of online resources that, as a new and younger generation joins the political ranks, is increasingly relied upon as a primary source of information. It will outline the emergence of science blogs, and present specific examples of their impact on both the advancement of science and public perception of science. The panel will provide some strategies for how blogs can be used by parliamentarians, advisors and policy makers. The final speaker will take stock of science blogging resources in Canada and present the Canadian science blog network.

Here’s a list of the speakers along with their bios. (from the 2013 CSPC panel webpage),

Rees Kassen
Co-Chair
Global Young Academy

Dr. Rees Kassen is professor and University Research Chair in Experimental Evolution at the University of Ottawa. He is also co-chair of the Global Young Academy (www.globalyoungacademy.net), an international organization of early-career researchers acting as the voice of young scientists around the world and past chair of the Partnership Group for Science and Engineering (PAGSE; www.pagse.org), an association of 26 professional and scientific organizations acting on behalf of over 50,000 members from academia, industry and government in Canada. Dr Kassen completed his PhD at McGill University and then went on to an NSERC Postdoctoral Fellowship and Elizabeth Wordsworth Research Fellowship at St Hugh’s College, Oxford. He is known internationally for his integrative approach to the study of biodiversity and pioneering work using microbes to study evolutionary and ecological processes in the laboratory. He was awarded an NSERC Steacie Fellowship in 2010 and was a World Economic Forum/IAP Young Scientist in 2010 and 2011.

Sarah Boon
Associate Professor of Environmental Science
University of Lethbridge

Sarah Boon is an Associate Professor of Environmental Science at the University of Lethbridge. She has worked in the Arctic and the western Cordillera on topics ranging from mountain pine beetle effects on snow processes, to stream temperature and salmonids. She’s also a science writer and editor, and blogs at Watershed Moments. A hydrologist by training, Sarah has written opinion pieces on both science policy and science communication. She is part of a team developing a Canadian science blog aggregator, to build Canadian science communication networks.

Kennedy Stewart
Member of Parliament (NDP)

Kennedy Stewart was elected to the riding of Burnaby-Douglas for the New Democratic Party in May 2011. He is the Official Opposition Critic for Science and Technology, and member of the Standing Committee on Industry, Science and Technology. Kennedy holds a Ph.D. in Government from the London School of Economics and is a tenured associate professor on leave from Simon Fraser University’s School of Public Policy. While at SFU, Kennedy authored numerous refereed publications and was awarded grants from the Social Sciences and Humanities Council of Canada and other organizations as principal investigator and was joint investigator on a $2.5 Million SSHRC Major Collaborative Research Initiative on Multilevel Governance and Public Policy in Canadian Municipalities. Before coming to SFU in 2002, Kennedy held a number of positions at Canadian and UK universities and was Director of the Public Policy and Management Master’s Program at Birkbeck College, University of London. He has served as a referee for various academic journals including British Columbia Studies, Canadian Journal of Political Science, Canadian Journal of Sociology, Canadian Political Science Review, Canadian Journal of Urban Research, Thomson/Nelson Press and has been reviewed grants for the Social Sciences and Humanities Research Council of Canada. As an academic, Kennedy frequently provided commentary on on local, national and international issues and was a regular guest columnist for the Vancouver Sun. He served as policy advisor to the British Columbia Local Government Elections Task Force, City of Vancouver Electoral Reform Commission, British Columbia Citizens’ Assembly, British Columbia Ministry of Municipal Affairs, Abu Dhabi Urban Planning Council, the Great Bear Rainforest Solutions Project, City of Vancouver Mayor’s Office, City of Calgary, and the Vancouver Public Library. His latest co-authored book, Local Government in Canada, was published in 2012 by Nelson. Kennedy is married to Jeanette Ashe, a political science instructor at Douglas College completing her Ph.D. in politics at the University of London.

David Kent
Research Associate
University of Cambridge, UK

Dr. David Kent is a research associate at the University of Cambridge, UK. In 2009 he created The Black Hole website which provides analysis of issues related to the education and training of scientists in Canada. He also writes for Signals blog, a leading source of commentary on stem cells and regenerative medicine. Previously, Dr. Kent served as joint coordinator for the UBC branch of the Let’s Talk Science Partnership Program (2004-07), an award winning national science outreach program. Dr. Kent grew up in St. John’s, NL, obtained a B.Sc. in Genetics and English Literature at the University of Western Ontario and completed his Ph.D. in blood stem cell biology at the University of British Columbia. He has been awarded scholarships or fellowships from the CIHR, NSERC, the Canadian Stem Cell Network, the Michael Smith Foundation for Health Research, and the Lady Tata Memorial Trust. His current laboratory research focuses on normal blood stem cells and how changes in their regulation lead to cancers. He also sits on the executive of the Canadian Association of Postdoctoral Scholars.

Lisa Willemse
Director of Communications
Stem Cell Network

Lisa Willemse has worked within government-funded research networks for the past 13 years as a project manager and communications specialist. She is currently the Director of Communications for the Stem Cell Network, one of Canada’s Networks of Centres of Excellence, a position she has held since 2008. In addition to more traditional forms of communications, such as the creation of two science exhibitions, Lisa was an early adopter of new media and has used social media platforms such as Twitter to establish the Stem Cell Network as a leader among its peers. In 2008, she began developing a blog dedicated to sharing findings and commentary related to stem cell research that would also serve as a training/mentorship platform for young scientists interested in acquiring science communications skills. She serves as the blog’s editor in chief and an occasional contributor. This blog, Signals, is widely regarded as one of the best in the stem cell field and enjoys a robust following by readers from across the globe.

Mike Spear
Director of Corporate Communications
Genome Alberta

Mike Spear is currently Director of Corporate Communications for Genome Alberta, a non-profit genetic research funding organization based in Calgary, Alberta, Canada. Prior to that much of his career was spent as a Producer, Executive Producer, and Program Manager with the Canadian Broadcasting Corporation. While there he received a CBC President’s award, a Farm Writer’s Award and his newsrooms and current affairs programs received several CBC Peer Awards and RTNDA Awards. He has worked in broadcast news, current affairs, music and drama and was a media trainer with the National Democratic Institute in Croatia. He has launched the conservative world of biotechnology communications into the 21st century with the creation of GenOmics, a news aggregator based on an Open Source platform Genome Alberta has supported with U.S. based partners. He and Genome Alberta are heavily involved in the Fall 2013 launch of Science Borealis, a new Canadian Science blogging network.

I would prefer a little more description, in each précis, about what the individuals will be discussing. I could do with a little less biography. For example, congratulations to Kennedy Steward for being married but I don’t find the information pertinent here. Also, I would have liked to have seen a little more information about the panel members’ blogs, although it seems only Sarah Boon and David Kent write on a blog(s).

One other session caught my attention and that was the one concerning intellectual property (patents) which was held on Nov. 21, 2013. The session was organized by Agriculture and Agri-Food Canada. From the P9: Courting Confusion: the Patent Act, legal decisions, and impacts on Canada’s science and innovation landscape webpage,,

“Canada’s Patent Act exists to encourage progress in science and the useful arts. It achieves this by securing inventors’ property rights in their inventions, thus establishing a market-based regime of incentives to foster innovation. Securing a patent is based on following logical, sound principles, unchanged in two centuries. The Patent Act itself establishes an order of steps that, if correctly followed, would resolve many controversial issues.

Under the act, a patentable invention must satisfy four main criteria: patent-eligible subject-matter; novelty; utility, and; non-obviousness. Novelty means new anywhere in the world. Utility is met where a person of ordinary skill, reading the specification, would understand the utility of the claimed invention. Non-obviousness requires that a persons of ordinary skill would not have been led to the claimed invention directly by the earlier teachings of others.

Recently, the scope of patent-eligible subject-matter has been controversial in pharmaceuticals, the life sciences; and in business methods, particularly involving computer software.

However, in the past few years, Canadian courts, including the Supreme Court of Canada (SCC), have issued rulings which may be seen as inconsistent or confusing in areas of patent-eligibility, novelty, utility, and non-obviousness . Canada does not have a specialized patent court, and the volume of litigation is insufficient to yield a finely developed body of law. Few judges have a technical or scientific background; fewer still have a background in patents.

This session will discuss how these issues have played out in several recent high profile cases and their implications for Canada’s science and innovation landscape.

In a modern agricultural context, the patenting of higher life forms is controversial, and has been the subject of two high-profile SCC decisions: Harvard College v. Canada (Commissioner of Patents) (the “Harvard Mouse” case), and Monsanto Canada Inc. v. Schmeiser (2004), which centered on patent infringement for genetically-engineered (GE) canola.

The 5-4 decision in the Schmeiser case led to concerns amongst anti-GE and some civil society and consumer groups about the ability to patent “the genes of life” and quasi-related unease about corporate concentration in the agriculture and food sectors. However, stakeholders in the agricultural biotechnology sector received the decision positively, as it affirmed the validity of their gene and cell patents and demonstrated that they could successfully seek redress for infringement.

In the Amazon.com case, the Federal Court of Appeal faced the issue of patent-eligibility of business methods, particularly those implemented by software applications. Although there had been hope that the Amazon.com case would bring clarity to the law, the outcome has been enigmatic. The patenting of business methods was also the subject of considerable debate in submissions before the House of Commons Standing Committee on Industry, Science and Technology for their March 2013 report on the Intellectual Property Regime in Canada.

Recently, the courts have had difficulty with utility. Odd decisions in the pharmaceutical field are now yielding equally surprising results in other business sectors. These cases and other practice changes have altered the balance between inventors and the public, and their effects now working their way through the economy.”

The moderator and the panelists are (from the session webpage),

Albert L. Abaunza
Co-founder
Abaunza McLeod LLP – Intellectual Property Law Canada

Albert L. Abaunza graduated from Université de Montréal in 2006 with a B.Sc. in biomedical science. During his undergraduate studies, Albert worked as a research assistant in pharmacology and biochemistry, where he studied the effects of reactive oxygen species (ROS) on the catalytic activity of the hepatic cytochrome P450 and participated in a high-throughput screening project for protein-protein interactions in a yeast model by using Protein-fragment complementation assay.

While studying biomedical science, Albert became involved in the planning and orchestration of the McGill Bioethics Conference for two consecutive years as VP Administration and VP External

After graduating in 2006, Albert decided to pursue his law studies at the Université de Sherbrooke and at Queen’s University where he was admitted to the national joint program and was granted a dual law degree; a Bachelors of laws (LL.B.) and a Juris Doctor (J.D.), in 2009 and 2010, consecutively.

During his last year of law school, Albert was concurrently focused on a specialization in health technology assessment and management. After having successfully completed the international program in four different cities; Barcelona, Rome, Montréal and Toronto, Albert was granted a M.Sc. degree in health technology assessment from Université de Montréal in 2012.

In 2013, Albert joined forces with Dr. Mark C. McLeod and co-founded Abaunza McLeod LLP – Intellectual Property Law Canada, where together and with the support of other well-seasoned IP practitioners, they provide a full spectrum of intellectual property law services in English, French and Spanish.

Ken Bousfield
Partner
Bereskin and Parr

Mr. Bousfield has significant experience in the railroad industry and has also obtained protection for consumer goods, oil field equipment, and a wide variety of mechanical and electro-mechanical other devices. He is a member of the Intellectual Property Institute of Canada’s (IPIC) Information Technology Committee.

Prior to being admitted to the bar, Mr. Bousfield obtained significant industry experience working as a designer and test engineer for an electronic equipment manufacturer and for an aircraft company.

Brian Gray
Senior Partner
Norton Rose

Brian Gray’s practice at Norton Rose focuses on litigation and dispute resolution in patent, copyright, trade-mark and advertising matters. He provides strategic advice concerning intellectual property matters and advises on the intellectual property and technology aspects of transactions.
Mr. Gray has taught patent and trade-mark law at the University of Toronto and has taught copyright law at McGill University. Mr. Gray has authored numerous papers on patent, trade-mark, trade secret, copyright and technology transfer.

He is on the editorial board of World Intellectual Property Report, Federated Press Intellectual Property Quarterly and of World E-Commerce Report and has also served on the editorial board of the Trade-Mark Reporter.

From 1989 to 1999 Mr. Gray was a member of Canada’s National Biotechnology Advisory Committee, appointed by the Minister of Industry to advise on science policy. He has also served as counsel for the intervener – Canadian Banking Association and the Canadian Life and Health Insurance Association – in the Amazon case.

Richard Gold
James McGill Professor
McGill University – Faculty of Law

Dr. Richard Gold is a James McGill Professor at McGill University’s Faculty of Law where he was the founding Director of the Centre for Intellectual Property Policy. He is also an Associate Member of the Department of Human Genetics at McGill’s Faculty of Medicine. He teaches in the area of intellectual property and innovation. His research centres on the nexus between innovation systems and intellectual property,with an emphasis on the life sciences.

Professor Gold has provided advice to Health Canada, Industry Canada, the Canadian Biotechnology Advisory Committee, the Ontario Ministry of Health and Long-Term Care, the Organisation for Economic Cooperation and Development (where he was the lead author of the OECD Guidelines on the Licensing of Genetic Inventions and a report on Collaborative Mechanisms in Life Science Intellectual Property), the World Intellectual Property Organization, the World Health Organization and UNITAID.

His research has been published in high-impact journals in science, law, philosophy, international relations including Nature Biotechnology, The Lancet, PLoS Medicine, the McGill Law Journal, Public Affairs Quarterly and the European Journal for International Relations.

Giuliano Tolusso
Senior Policy Officer
Agriculture and Agri-Food Canada

Giuliano Tolusso is a senior policy officer with Agriculture and Agri-Food Canada in Ottawa. He has spent most of the past decade at AAFC working on biotechnology and emerging technology issues from a number of perspectives including communications and issues management, intellectual property policy and international trade policy. Prior to joining AAFC in 2001, Giuliano was a marketing and communications executive for a number of trade and professional associations in Toronto. He holds a Bachelor of Journalism degree from Carleton University in Ottawa.

At last year’s CSPC, he organized and moderated a provocative panel discussion entitled Talking to Canadians about Biotechnology: Should we wake up the neighbourhood

Anyone who has read this blog with any frequency knows I’m not a maximalist where intellectual property is concerned. Further, I have observed that most lawyers seem interested in having more patents rather than fewer patents. After all, that’s how they make their money.

Getting back to the panel, it can’t escape anyone’s notice that it is almost entirely made up of lawyers with two exceptions being a policy officer from the agency listed as the session organizer and an academic lawyer. The whole thing seems odd as it is a discussion on points of law and would appear to be of interest to lawyers only. How would attending this session help a ‘would be’ scientist innovator/inventor/entrepreneur? Perhaps it’s meant for policy makers but if that’s the case, wouldn’t a comprehensive discussion about patents and their utility be more useful than a  discussion about specific legal decisions? (They say they will discuss more general points but first they’ll have to describe the cases pertaining to the specific decisions under discussion which will take up much of the time allotted for the session.)

Given the 2013 CSPC conference theme: ScienceNext: Incubating Innovation and Ingenuity, I would have thought that perhaps an opinion from potential investors or successful entrepreneurs might be of interest in a discussion about patents. For example, Mike Masnick writes in his Nov. 14, 2013 posting for Techdirt about research which suggests venture capitalists find the current US patent regime problematic (Canadians and others file many of their patents in the US),

… The idea that patents are what drive investments definitely does not appear to be the case.

The related bit of information is a new research study, done by Robin Feldman, looking at the view of patents from the venture capital perspective, surveying around 200 venture capitalists and their portfolio companies about their views on patents — which are decidedly negative:

Both the companies and the venture capitalists overwhelming believe that patent demands have a negative impact on the venture-backed community, with all or most of those assertions coming from entities whose core activity involves licensing or litigating patents. These impacts are described in terms of the specific costs expended by the companies and by the distraction to management, engineers, and other employees. Most important, participants described the human toll that patent demands have had on entrepreneurs. In addition, when making funding decisions, the vast majority of venture capitalists do not consider the potential for selling to assertion entities if the company fails. On the flip side, 100% of venture capitalists indicated that if a company had an existing patent demand against it, it could potentially be a major deterrent in deciding whether to invest.

In other words: having patents does not significantly impact the decision to invest, but being the target of patent trolls has significant consequences for entrepreneurs, and makes investors less willing to invest in important innovations.

In any event, I hope the science blogging panel is a huge success and for anyone who’s curious about an outside perspective on the 2013 CSPC, there’s David Bruggeman’s Nov. 19, 2013 posting on his Pasco Phronesis blog (where he regularly comments on science policy).